Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 27;2022:4000617. doi: 10.1155/2022/4000617

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Wu Zhang et al.

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

MT1G is an independent adverse prognostic factor in clear cell renal cell carcinoma (ccRCC) patients. (a) The survival curve of MT1G in ccRCC: the higher the expression level of MT1G, the shorter the survival time. (b) The receiver operating characteristic curve: AUC = 77.223. (c) Multivariate cox analysis showing the hazard ratios of different factors. The number of events for the number of tested factors was 92. The global p value (log-rank) was 2.4845e − 11, Akaike's information criterion was 834.63, and the concordance index was 0.79. (d) The expression level of MT1G was correlated with grade (p=0.032). (e) The expression level of MT1G was correlated with TNM stage (p < 0.001). (f) The expression level of MT1G was correlated with invasion depth (p=0.02).